HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the creation of its Scientific Advisory Board (SAB) to guide the Company’s ongoing research, development, and new product roadmaps. The SAB will meet quarterly and consists of five members, Harvard Bioscience President and CEO John Duke and four experienced industry leaders. “The formation of our […]

New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN Discovery Platform extends AI into drug discovery workflows QIAGEN builds on more than 25 years of biomedical knowledge, with QDI tools used by around 150,000 users VENLO, Netherlands & GERMANTOWN, Md. — QIAGEN N.V. […]

Collaboration brings EpiSign’s comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform LONDON, ON and HERZLIYA, Israel — EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation. The collaboration combines EpiSign’s expertise in DNA methylation episignature analysis […]

BOSTON, Mass. — Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED (“ARCHIMED”), a leading investment firm focused exclusively on healthcare industries. Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools, said, “ARCHIMED brings deep healthcare […]

Building a two-site demonstration laboratory system together with the semiconductor-focused facility in Bengaluru, Hitachi High-Tech aims to strengthen the provision of digitalized assets in the India market and also accelerating HMAX Industry TOKYO — Hitachi High-Tech Corporation (“Hitachi High-Tech”), has established a demonstration laboratory Advanced-Technology Innovation Center Mumbai for analytical systems in Mumbai, India (“Mumbai […]

Redwood City, CA, and Vienna, Austria – Biomay, a contract development and manufacturing organization (CDMO) specializing in mRNA manufacturing, lipid nanoparticle (LNP) formulation, aseptic fill-finish, plasmid DNA, and recombinant proteins, and Synthego, a leading provider of CRISPR solutions, today announced a non-exclusive collaboration to market, promote, and resell Biomay products and services to Synthego customers […]

WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that, effective today, Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer and has joined Danaher’s Board of Directors, as previously announced on August 3, 2026. Since joining the Company in 2017, Ms. Sawyer Montgomery has held roles of increasing responsibility […]

New software extends automated analysis of more than 300 episignature disorders beyond methylation microarrays to Illumina 5-base, PacBio HiFi and Oxford Nanopore sequencing data LONDON, ONTARIO — EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA methylation data. EpiSign METRIC […]

Sitges, Spain – MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life science, today launched its Stereo-seq OMNI Large Chip Design for formalin-fixed, paraffin-embedded (FFPE) samples at the third Conference of the European Society for Spatial Biology (ESSB), held from 28 September to 1 October at […]

New Patent Protects the CleanCap® Cap Analog Compounds Themselves and mRNA-Based Pharmaceutical Compositions — Extending Beyond Method Claims to Cover the Molecules at the Heart of Modern mRNA Medicines SAN DIEGO — TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, today announced it has […]